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Objective/background: The present investigation was undertaken to synthesize zinc oxide
nanoparticles using Limonia acidissima L. and to test their efficacy against the growth of
Mycobacterium tuberculosis.
Methods: The formation of zinc oxide nanoparticles was confirmed with UV–visible spec-
trophotometry. Fourier transform infrared spectroscopy shows the presence of bio-
molecules involved in the stabilization of zinc oxide nanoparticles. The shape and size
was confirmed with atomic force microscope, X-ray diffraction, and high resolution trans-
mission electron microscope. These nanoparticles were tested for their effect on the
growth of M. tuberculosis through the microplate alamar blue assay technique.
Results: The UV–visible data reveal that an absorbance peak at 374 nm confirms formation
of zinc oxide nanoparticles and they are spherical in shape with sizes between 12 nm and
53 nm. These nanoparticles control the growth of M. tuberculosis at 12.5 lg/mL.
Conclusion: Phytosynthesis of zinc oxide nanoparticles is a green, eco-friendly technology
because it is inexpensive and pollution free. In the present investigation, based on our
results we conclude that the aqueous extract of leaves of L. acidissima can be used for
the synthesis of zinc oxide nanoparticles. These nanoparticles control the growth of
M. tuberculosis and this was confirmed with the microplate alamar blue method. The
potential of biogenic zinc oxide nanoparticles may be harnessed as a novel medicine
ingredient to combat tuberculosis disease.
 2016 Asian-African Society for Mycobacteriology. Production and hosting by Elsevier Ltd.
All rights reserved.Introduction
In modern science, the entire biological field has been using
nanotechnology within a short amount of time. This era of
nanotechnology helps in the production of materials at the
smallest possible scale. Nanotechnology has considerablyimproved and revolutionized plenty of technologies that are
used in industrial sectors including food safety, medicine,
and other fields. Zinc oxide nanoparticles are used in the gen-
eration of biological applications including semiconducting,
piezoelectric, and pyroelectric properties, and have versatile
applications in transparent electronics, UV light emitters,ate Nagar
Fig. 1 – (A) Limonia acidissima L. leaves; (B) habitat of the
plant.
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oxide nanoparticles with various sizes and shapes have been
widely exploited in numerous technological applications as
biosensors in medical diagnostics [3]. Zinc oxide nanoparti-
cles have also been proposed as antimicrobial preservatives
for wood and food products [4,5]. Nanoparticles enhance the
immobilization and activity of catalysts in the pharmaceuti-
cal industry [6,7], gas sensors [7], antimicrobial activity [8]
electronic nanodevices, and UV filters [9] due to the novel
properties exhibited by the material. For all these require-
ments of nanoparticles different methods are developed via
physical, chemical, and biological methods; however, these
physicochemical methods [10] generate large amounts of
hazardous by-products. Biological methods are simple, eco-
friendly reaction protocols for the synthesis of nanoparticles
by using plant extracts that provide a biological synthesis
route of several metallic nanoparticles which are more eco-
friendly and allows capping, reduction, and control with
well-defined size and shape. The bio-fabrication of zinc
nanoparticles by Justicia adhatoda leaf extract [11] and Aloe bar-
badensis leaf extract are used to synthesize zinc oxide
nanoparticles [12], gold nanoparticles are synthesized by
using plants such as lemon grass and neem [13,14], and Limo-
nia acidissima leaf extract has been used for the synthesis of
silver nanoparticles [15]. Zinc oxide as a nontoxic, inexpen-
sive, and nonhygroscopic polar inorganic crystalline material
is very economical, safe, and easily available Lewis acid cata-
lyst, which has gained much interest in various organic trans-
formations, sensors, transparent conductors, and surface
acoustic-wave devices [16–18].
Tuberculosis (TB) continues to be one of the leading causes
of death worldwide. The World Health Organization declared
TB as a global emergency in 1993. According to a recent World
Health Organization report, there were 1.5 million TB-related
deaths in 2014. TB is the world’s second most common cause
of death after human immunodeficiency virus/AIDS. The
presence of immunosuppressive factors like diabetes, alco-
holism, malnutrition, chronic lung disease, and human
immunodeficiency virus/AIDS may increase the chances of
TB infection [19,20]. The disease affects the lungs mainly,
but can also develop as pulmonary TB in the central nervous
system, circulatory system, or elsewhere in the body [21].
Available TB treatment involves daily administration of
four oral antibiotics for a period of P6 months [22]. Due to a
high percentage of side effects (ototoxicity and nephrotoxic-
ity) and the extended duration of treatment results in low
patient adherence [23]. Based on this concept the field of nan-
otechnology focuses on the preparation of TB diagnostic kits
which are currently under trial. This technology does not
require any skill and is cost effective. Another significant
advancement of this technology is that the use of nanoparti-
cles as drug carriers has high stability and carrier capacity.
Today, different types of nanoparticles are used to control
the growth of Mycobacterium tuberculosis viz the alginate
nanoparticles help the bioadhesive characteristics of intesti-
nal mucosa therapy which increases the time period available
for its absorption [24]. Chitosan, rifampicin, and polyethylene
glycol nanoparticles are used in the controlled delivery sys-
tem for TB treatment [25]. Banu and Rathod [26] used biogenic
silver nanoparticles to inhibit the growth of M. tuberculosis[26]. The decoction of L. acidissima leaves are used for the
treatment of constipation, vomiting, and also as a cardiotonic
and diuretic in Indian folk medicine [27]. The leaves are
reported to possess hepatoprotective activity [28]. Leaves,
bark, and fruits of this plant have been used in traditional
medicine for centuries due to their antimicrobial [29], anti-
fungal [30], astringent, anti-inflammatory [31], and insulin
secretagogue [32] activities. Essential oil isolated from the
leaves has antibacterial and antifungal activity [33]. In view
of all these aspects, the present investigation was undertaken
to bio-fabricate zinc oxide nanoparticles using L. acidissima
leaf extract and to test their efficacy against TB bacterial
growth.Materials and methods
L. acidissima Linn. Syn. Feronia elephantum Correa, (wood apple)
is a medicinally important plant (Fig. 1A and B). It is a moder-
ate sized deciduous tree grown throughout India. Dark green-
ish fresh leaves of wood apple without any infection were
sampled from the botanical garden at Karnatak University,
Dharwad Karnataka, India, and zinc nitrate (Hi-media, Mum-
bai, India) was used for the biosynthesis of zinc oxide
nanoparticles.Preparation of the plant extract
Twenty grams of fresh leaves were washed with tap water fol-
lowed by Milli-Q water and then were dried, finely cut, and
soaked in a 250-mL Erlenmeyer flask containing 100-mL
Milli-Q water and boiled at 60 C for 1 h. The leaf extract
was allowed to cool at room temperature, filtered through
Whatman number-1 filter paper, and the filtrate was stored
at 4 C for further experimental use.
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Fig. 2 – UV–visible spectrum of zinc oxide nanoparticles
synthesized by leaf extract of Limonia acidissima. Note.
Abs = absorbance.
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Five milliliters of the extract was added to a 95-mL zinc
nitrate solution in a 250-mL Erlenmeyer flask, and incubated
at 80 C for 10 min. The pH was adjusted to 10 using 0.1 N
HCl or 0.1 N NaOH. Reduction of zinc ions to zinc nanoparti-
cles was observed after 72 h. The leaf extract and zinc nitrate
were maintained as controls throughout the experimental
period.
Characterization was done with a UV–visible spectropho-
tometer (Jasco Corporation, Tokyo, Japan) at a resolution of
1 nm, with a wavelength range of 300–600 nm. The solution
was centrifuged (Remi R-8C) at 4500 g for 40 minutes, and pel-
lets were redispersed in Milli-Q water. The centrifugation and
dispersion were repeated to ensure the removal of excess bio-
molecules. The purified pellets were dried in an oven, sub-
jected to the fourier transform infrared spectroscopy with
the help of KBr pellets, and recorded the spectrum (U-3010
spectrophotometer) at a resolution of 4 nm with a range of
400–4000 cm1. Particle size and distribution of the nanoparti-
cles were determined using an atomic-force microscopy
(AFM) and high-resolution transmission electron microscopy
(HR-TEM) model of Tap190Al-G of nanosurf easy scan2 and
JEOL 3010, respectively. An energy-dispersive X-ray spectrom-
eter was used for analysis (EDAX-TSL Ametek).
Anti-TB activity using microplate alamar blue dye assay
method
The anti-TB activity of zinc oxide nanoparticles was assessed
against M. tuberculosis (H37 RV strain) American Type Culture
Collection No-27294 using a standard microplate alamar blue
dye assay method [34]. This method is nontoxic, employs a
thermally stable reagent, and shows good correlation with
proportional and BACTEC radiometric methods. Two-
hundred microliters of sterile deionized water was added to
all outer perimeter wells of a sterile 96 well plate to minimize
evaporation of the medium from the test wells during incuba-
tion. The 96 wells of the plate received 100 lL of Middlebrook
7H9 broth and a serial dilution of zinc oxide nanoparticles
were made directly on the plate. The final zinc oxide nanopar-
ticle concentrations tested were 0.8–100 lg/mL, and standard
antibiotics like pyrazinamide, ciprofloxacin, and strepto-
mycin were used. Plates were covered and sealed with paraf-
ilm and incubated at 37 C for 5 days. After incubation, 25 lL
of the freshly prepared 1:1 mixture of alamar blue reagent
and 10% Tween 80 was added to the plate and incubated for
24 h. A blue color in the well was considered as no bacterial
growth, and the pink color was scored as growth. The mini-
mum inhibitory concentration was defined as the lowest drug
concentration which prevented the color change from blue to
pink.
Results and discussion
The biological approaches for the synthesis of zinc oxide
nanoparticles using L. acidissima leaf extract at 80 C for a
10-min duration for the reduction of zinc nitrate to zinc oxide
nanoparticles by bioreduction, stabilizing, and capping withleaf extract, has a peak at 374 nm in the UV–visible spectra
data (Fig. 2) which this is very similar to the synthesis of zinc
oxide nanoparticles by Parthenium leaf extract [8].
Fig. 3 and Table 1 shows the Fourier transform infrared
spectroscopy spectrum recorded from the zinc oxide
nanoparticles obtained after oven drying of the centrifuged
fine powder. The amino acid residue and the peptide of pro-
tein presents the well-known signature in the infrared region
of the electromagnetic spectrum. The phenol molecules are
present at 3412 cm1 stretching vibration, and the 1610-
cm1 band reveals the carboxylate group. The peak at
1056 cm1 was assigned to the Si–O–Si stretching vibration
of proteins while their weak bending vibrations of
1268 cm1 was assigned to the carbonyl stretching vibration
of guaiacyl ring. The 1409-cm1 band represents the C–C
stretching of the aromatic ring. The infrared study reveals
the presence of aromatic ring proteins and amide bonds have
a strong ability for the formation and covering of metal
nanoparticles. The characteristic absorption peak of the zinc
oxide bond was found to be 543 cm1 [35,36].
Fig. 4 shows the strong signals of zinc and oxygen atoms in
the nanoparticles recorded in the energy dispersive X-ray
analysis, and other signals from C, Mg, Ca, and Si atoms were
also observed.
The morphology and size of nanoparticles were ascer-
tained from the AFM and HR-TEM images. AFM data reveal
that the particles are monodispersed and spherical in shape
and that the size ranges from 12 nm to 53 nm (Fig. 5A) in
two- and three-dimensional structures of the nanoparticles
with a height of 14.4 nm (Fig. 5B). The distance from each
other is 11.3–56.52 nm (Fig. 5C). The particles are spherical
in shape and some of the particles are agglomerates. The
HR-TEM image confirms the formation of zinc oxide nanopar-
ticles and they have an average size of about 12–53 nm (Figs. 5
and 6). The obtained zinc oxide nanoparticles are similar to
that of A. barbadensis [12].
XRD was performed to further confirm the action of the
zinc oxide phase of the nanoparticles. The XRD of the
obtained nanoparticles is shown in Fig. 7. The XRD peaks
were identified as (100), (002), (101), (102), (110), and (112)
Fig. 3 – Fourier transform infrared spectroscopy spectrum of biogenic zinc oxide nanoparticles.
Fig. 4 – Energy-dispersive X-ray spectrometer spectrum of zinc oxide nanoparticles.
Table 1 – Fourier transform infrared spectroscopy absorption peaks and their associated functional groups involved in the
biosynthesis of zinc oxide nanoparticles.
Serial no. Absorption peak (cm1) in zinc oxide nanoparticles Bond/functional groups
1 543.98 Stretching of hydroxyl group
2 809.16 Waging of secondary amines
3 1056.45 Si–O–Si stretching vibration of proteins
4 1268.36 C–O stretching vibration of guaiacyl ring
5 1409.40 C–C stretching of aromatic ring
6 1506.79 N–O asymmetric stretching of nitro compounds
7 1610.55 C@C stretching of vinyl alkyl ethers
8 2852.00 C–CH2 groups in chitosan or oleic acid
9 2931.48 C–H stretching vibrations of alkanes
10 3412.77 O–H stretching vibrations of phenol group
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Fig. 5 – (A) Two-dimensional structure; (B) three-dimensional image; (C) particle size distribution of zinc nanoparticles.
Fig. 6 – High-resolution transmission electron microscopy
image of zinc oxide nanoparticles.
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Fig. 7 – X-ray powder diffraction spectrum of zinc oxide
nanoparticles with Bragg’s diffraction values shown in
parentheses. The absorbance is expressed in terms of
arbitrary unit (a.u.).
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indexed to the spherical and hexagonal zinc oxide phase by
comparison with the data from Joint Committee on Powder
Diffraction Standards card number 89-7102. The narrow and
strong diffraction peaks indicate that the product has a well
defined crystalline particle structure. The Scherrer formula
was used for the calculation of the particles sizes and found
to be in the range of 12–53 nm.
Effect of zinc oxide nanoparticles on M. tuberculosis
Reports from assays on the toxicity of zinc oxide nanoparti-
cles on the M. tuberculosis system are meager. However, there
are few reports on the toxic effects of alginate nanoparticles
which possess bioadhesive characteristics to intestinal
mucosa therapy which increases the time period available
for its absorption [24]. Chitosan, rifampicin, and polyethylene
glycol nanoparticles are used in controlled delivery systems
for TB treatment [25]. Banu and Rathod [26] used the biogenic
silver nanoparticles to inhibit the growth of M. tuberculosis
[26]. Table 2 and Fig. 1 shows the inhibition of M. tuberculosis
growth after being treated with zinc oxide nanoparticle solu-
tion. The bacteria were exposed to different concentrations
(0.8 lg/mL, 1.6 lg/mL, 3.12 lg/mL, 6.25 lg/mL, 12.5 lg/mL,
25 lg/mL, 50 lg/mL, and 100 lg/mL) of zinc oxide nanoparticle
solution and showed the bacterial sensitivity with increasing
concentrations of solution exposed to theM. tuberculosis. Zinc
nanoparticles after completion of the incubation period
showed a blue color in the well which is considered as no bac-
terial growth, and pink color is scored as a growth. Bacterial
growth was inhibited from 12.5 lg/mL to 100 lg/mL of zinc
oxide nanoparticles. However, at a concentration of 12.5 lg/
mL the zinc oxide nanoparticles have a minimum inhibitory
concentration or modest effect on bacterial growth. The
mycobacterium were sensitive at 100 lg/mL of leaf extract
but resistant to zinc nitrate solution in all concentrations
(Fig. 8 and Table 2). Standard antibiotics like pyrazinamide
and ciprofloxacin shows the minimum inhibitory concentra-
tion at 3.12 lg/mL but streptomycin shows 6.25 lg/mL.
The current investigation suggests that the biologically
synthesized zinc oxide nanoparticles from a medicinal plant
Fig. 8 – Microplatealamar blue assay method was used to determine the minimum inhibitory concentrations of biogenic zinc
oxide nanoparticles against Mycobacterium tuberculosis: (A) biogenic zinc nanoparticles; (B) zinc nitrate; (C) leaf extract.
Table 2 – Shows the results of antituberculosis activity.
Samples name Concentration (lg/mL)
100 50 25 12.5 6.25 3.12 1.6 0.8
ZnO NPs S S S S R R R R
Zinc nitrate R R R R R R R R
Leaf extract S R R R R R R R
Pyrazinamide S S S S S S R R
Ciprofloxacin S S S S S S R R
Streptomycin S S S S S R R R
Note. NPs = nanoparticles; R = resistant; S = sensitive.
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treatment of infectious diseases caused by pathogenic
microorganisms.
There are meager reports on the activity of zinc oxide
nanoparticles on M. tuberculosis. Although zinc oxide
nanoparticles can be internalized into bacteria, less or no
genotoxic potential has been reported in Salmonella typhimur-
ium and Escherichia coli [37,38]. In Fig. 8A, 100 lg/mL, 50 lg/mL,
25 lg/mL, and 12.5 lg/mL of zinc oxide nanoparticle solution
inhibited the growth of bacteria where the zinc oxide
nanoparticles initiate a lipid peroxidation reaction subse-Fig. 9 – Schematic diagram depicting the possible mechanism o
tuberculosis.quently causing DNA damage, glutathione depletion, disrup-
tion of membrane morphology, and electron transport
chain, which leads to cell apoptosis [39]. The concentration
and size (12–53 nm) are two important factors that may affect
cell apoptosis. In Fig. 9, the zinc oxide nanoparticles are found
to be attached on the surface of the bacterial cell membrane.
After that it enters into the cytoplasm of mycobacterium via
endocytosis and the smaller sized nanoparticles (12–53 nm)
penetrate the bacterial cell membrane which inactivates the
enzymes essential for adenosine triphosphate production
[7,40] that leads to the formation of reactive oxygen speciesf activity of zinc oxide nanoparticles on Mycobacterium
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nanoparticles may react with sulfur or phosphorus-
containing soft bases, such as R-S-R, R-SH, RS-, or PR3, and
it promotes the loss of DNA replication ability [42–44]. Thus,
the sulfur-containing protein in the membrane or inside the
cell and phosphorus-containing elements like DNA are likely
to be preferential sites for the action of zinc oxide nanoparti-
cles [44].
The inhibition depletes the sites of mycolic acid transfer to
the cell wall. Mycolic acids present in cell walls are known to
be specifically attached to the 5-position of distal D-arabinose
residue as shown by Azuma and Yamamura [45]. The deple-
tion of newly synthesized mycolic acids must find alternative
sites for transfer. This transfer is thought to be diverted to the
trehalose molecule, which causes overproduction of trehalose
monomycolate and trehalose dimycolate. This effect of
ethambutol may trigger a cascade of changes in the lipid
metabolism of Mycobacterium smegmatis and M. tuberculosis
leading to cell damage and eventually to cell apoptosis [46–
48]. Zinc oxide nanoparticles may bring about bacterial cell
apoptosis as with ethambutol. Fig. 9 shows the schematic rep-
resentation of the possible mechanism of activity of zinc
oxide nanoparticles on M. tuberculosis.
Conclusion
This investigation demonstrates that zinc oxide nanoparticles
can be synthesized through a green approach that is an inex-
pensive, pollution free, and eco-friendly method using
L. acidissima leaf extract as a bio-templating agent. The
biogenic zinc oxide nanoparticles are spherical in shape and
ranges from 12 nm to 53 nm. Based on this observation, an
interaction between zinc oxide nanoparticles and the cell
surface affects the permeability of the membrane where
nanoparticles enter and induce the generation of reactive
oxygen species in the bacterial cell, subsequently resulting
in the inhibition of cell growth and eventually resulting in cell
death.
Conflicts of interest
The authors have no conflicts of interest.
Acknowledgments
The authors thank the Chairman of the Postgraduate Depart-
ment of Studies in Botany, Karnatak University, Dharwad,
India, for providing the necessary facilities. B.N.P. acknowl-
edges the financial support in the form of a UGC–UPE: Univer-
sity Grant Commission–University with Potential for
Excellence fellowship (reference number KU/Sch/UGC-
UPE/2013-14/1101) and the UGC–DSA–I: University Grant
Commission–Departmental Special Assistance–I phase pro-
gram of the Department of Botany, Karnatak University, Dhar-
wad Campus. The authors also thank USIC: University
Scientific Instrumentation Centre, K.U. Dharwad, STIC:
Sophisticated Test and Instrumentation Centre, Kochin, SRM
University, and DST: Department of Science and TechnologyNano unit, IITM: Indian Institute of Technology Madras,
Chennai for providing the necessary instrumentation facility.R E F E R E N C E S[1] Z.L. Wang, Nanostructures of zinc oxide, Mater. Today 7
(2004) 26–33.
[2] M.S. Akhtar, S. Ameen, S.A. Ansari, et al, Synthesis and
characterization of ZnO nanorods and balls nanomaterials
for dye sensitized solar cells, J. Nanoeng. Nanomanuf. 1 (2011)
71–76.
[3] Z. Zhang, H. Chen, J. Zhong, et al, Nanotip-based QCM
biosensors, in: Proceedings of the IEEE International
Frequency Control Symposium and Exposition, 2006, pp. 545–
549.
[4] V. Aruoja, H. Dubourguier, C. Kasamet, et al, Toxicity of
nanoparticles of CuO, ZnO and TiO2 to microalgae
Pseudokirchneriella subcapitata, Sci. Total Environ. 407 (2009)
1461–1468.
[5] C.A. Clausen, S.N. Kartal, R.A. Arango, et al, The role of
particle size of particulate nano-zinc oxide wood
preservatives on termite mortality and leach resistance,
Nanoscale Res. Lett. 6 (2011) 427.
[6] P. Wang, Nanoscale biocatalyst systems, Curr. Opin.
Biotechnol. 17 (2006) 574–579.
[7] B. Baruwati, D.K. Kumar, S.V. Manorama, Hydrothermal
synthesis of highly crystalline ZnO nanoparticles: a
competitive sensor for LPG and EtOH, Sens. Actuators B
Chem. 119 (2006) 676–682.
[8] P. Rajiv, S. Rajeshwari, R. Venckatesh, Bio-fabrication of zinc
oxide nanoparticles using leaf extract of Parthenium
hysterophorus L. and its size-dependent antifungal activity
against plant fungal pathogens, Spectrochim. Acta A Mol.
Biomol. Spectrosc. 112 (2013) 384–387.
[9] S. Singh, P. Thiyagarajan, K.M. Kant, et al, Structure,
microstructure and physical properties of ZnO based
materials in various forms: bulk, thin film and nano, J. Phys.
D Appl. Phys. 40 (2007) 6312–6327.
[10] M. Li, H. Bala, X. Lv, et al, Direct synthesis of monodispersed
ZnO nanoparticles in an aqueous solution, Mater. Lett. 61
(2007) 690–693.
[11] T.C. Taranath, N.P. Bheemanagouda, T.U. Santosh, et al,
Cytotoxicity of zinc nanoparticles fabricated by Justicia
adhatoda L. on root tips of Allium cepa L.—a model approach,
Environ. Sci. Pollut. Res. 22 (2015) 8611–8617.
[12] G. Sangeetha, S. Rajeshwari, R. Venckatesh, Green synthesis
of zinc oxide nanoparticles by Aloe barbadensis miller leaf
extract: structure and optical properties, Mater. Res. Bull. 12
(2011) 2560–2566.
[13] S.S. Shankar, A. Rai, A. Ahmad, et al, Controlling the optical
properties of lemongrass extract synthesized gold
nanotriangles and potential application in infrared-
absorbing optical coatings, Chem. Mater. 17 (3) (2005) 566–
572.
[14] S.S. Shankar, A. Rai, A. Ahmad, et al, Rapid synthesis of Au,
Ag, and bimetallic Au core–Ag shell nanoparticles using
neem (Azadirachta indica) leaf broth, J. Colloid Interface Sci.
275 (2004) 496–502.
[15] N.P. Bheemanagouda, T.C. Taranath, Antituberculosis activity
of biogenic silver nanoparticles synthesized by using
aqueous leaf extract of Limonia acidissima L., Int. J. Pharm.
BioSci. 7 (2016) 89–97.
[16] K. Bahrami, M.M. Khodaei, A. Nejati, One-pot synthesis of
1,2,4,5-tetrasubstituted and 2,4,5-trisubstituted imidazoles
204 I n t e r n a t i o n a l J o u r n a l o f M y c o b a c t e r i o l o g y 5 ( 2 0 1 6 ) 1 9 7 –2 0 4by zinc oxide as efficient and reusable catalyst, Monatsh.
Chem. 142 (2011) 159–162.
[17] R. Tayebee, F. Cheravi, M. Mirzaee, et al, Commercial zinc
Oxide (Zn2
+) as an efficient and environmentally benign
catalyst for homogeneous benzoylation of hydroxyl
functional groups, Chin. J. Chem. 28 (2010) 1247–1252.
[18] C.R. Gorla, N. Emanetoglu, W.S. Liang, et al, Structural,
optical, and surface acoustic wave properties of epitaxial ZnO
films grown on (01–12) sapphire by metalorganic chemical
vapor deposition, J. Appl. Phys. 85 (1999) 2595–2602.
[19] B.J. Marais, K. Lonnroth, S.D. Lawn, et al, Tuberculosis
comorbidity with communicable and non-communicable
diseases: integrating health services and control efforts,
Lancet Infect. Dis. 13 (2013) 436–448.
[20] I.G. Sia, M.L. Wieland, Current concepts in the management
of tuberculosis, Mayo Clin. Proc. 86 (2011) 348–361.
[21] R.B. Rock, M. Olin, C.A. Baker, et al, Central nervous system
tuberculosis: pathogenesis and clinical aspects, Clin.
Microbiol. Rev. 21 (2008) 243–261.
[22] L.C. du Toit, V. Pillay, M.P. Danckwerts, Tuberculosis
chemotherapy: current drug delivery approaches, Respir. Res.
7 (2006) 118.
[23] C. Aagaard, J. Dietrich, M. Doherty, et al, TB vaccines: current
status and future perspectives, Immunol. Cell Biol. 87 (2009)
279–286.
[24] Z. Ahmad, R. Pandey, S. Sharma, et al, Alginate nanoparticles
as antituberculosis drug carriers: formulation development,
pharmacokinetics and therapeutic potential, Indian J. Chest
Dis. Allied Sci. 48 (2006) 171–176.
[25] M. Rajan, V. Raj, Encapsulation, characterization and in-vitro
release of anti-tuberculosis drug using chitosan-poly
ethylene glycol nanoparticles, Int. J. Pharm. Pharm. Sci. 4
(2012) 255–259.
[26] A. Banu, V. Rathod, Biosynthesis of monodispersed silver
nanoparticles and their activity against Mycobacterium
tuberculosis, J. Nanomed. Biother. Discov. 3 (2013) 1–5.
[27] T.K. Chatterjee, Herbal Options, third ed., Books and Allied (P)
Ltd., Calcutta, 2000, pp. 203–256.
[28] C.D. Kamat, K.R. Khandelwal, S.L. Bodhankar, et al,
Hepatoprotective activity of leaves of Feronia elephantum
Correa (Rutaceae) against carbon tetrachloride induced liver
damage in rats, J. Nat. Remedies 3 (2003) 148–154.
[29] B.M.R. Bandara, C.M. Hewage, D.H.L.W. Jayamanne, et al,
Biological activity of some steam distillates from leaves of ten
species of rutaceous plants, J. Nat. Sci. Counc. 18 (1990) 71–77.
[30] N.K.B. Adikaram, Y. Abhayawardhane, A.A.L. Gunatilaka,
et al, Antifungal activity, acid and sugar content in the wood
apple (Limonia acidissima) and their relation to fungal
development, Plant Pathol. 38 (2007) 258–265.
[31] K.H. Kim, S.K. Ha, S.Y. Kim, et al, Limodissimin A: a new
dimeric coumarin from Limonia acidissima, Bull. Korean
Chem. Soc. 30 (2009) 2135–2137.
[32] R. Gupta, S. Johri, A.M. Saxena, Effect of ethanolic extract of
Feronia elephantum Correa fruits on blood glucose level in
normal and streptozotocin-induced diabetic rats, Nat. Prod.
Rad. 8 (2009) 32–33.
[33] R.K. Joshi, V.M. Badakar, S.D. Kolkute, et al, Chemical
composition and antimicrobial activity of the essential oil ofthe leaves of Feronia elephantum (Rutaceae) from north west
Karnataka, Nat. Prod. Commun. 6 (2011) 141–143.
[34] M.C.S. Lourenc¸o, M.V.N. de Souza, A.C. Pinheiro, et al,
Evaluation of anti-tubercular activity of nicotinic and
isoniazid analogues, Arkivoc (2007) 181–191.
[35] K. Nejati, Z. Rezvani, R. Pakizevand, Synthesis of ZnO
nanoparticles and investigation of the ionic template effect
on their size and shape, Int. Nano Lett. 1 (2011) 75–81.
[36] H. Kumar, R. Rani, Structural and optical characterization of
ZnO nanoparticles synthesized by microemulsion route
international letters of chemistry, Int. Lett. Chem. Phys.
Astron. 14 (2013) 26–36.
[37] A. Kumar, A.K. Pandey, S.S. Singh, et al, Cellular uptake and
mutagenic potential of metal oxide nanoparticles in bacterial
cells, Chemosphere 83 (2011) 1124–1132.
[38] S.H. Nam, S.W. Kim, Y.J. An, No evidence of the genotoxic
potential of gold, silver, Zinc oxide and titanium dioxide
nanoparticles in the SOS chromotest, J. Appl. Toxicol. 33
(2013) 1061–1069.
[39] A. Kumar, A.K. Pandey, S.S. Singh, et al, Engineered ZnO and
TiO2 nanoparticles induce oxidative stress and DNA damage
leading to reduced viability of Escherichia coli, Free Radic. Biol.
Med. 51 (2011) 1872–1888.
[40] Q.L. Feng, J. Wu, G.Q. Chen, et al, A mechanistic study of the
antibacterial effect of silver ions on Escherichia coli and
Staphylococcus aureus, J. Biomed. Mater. Res. 52 (2000) 662–668.
[41] S. Mohanty, P. Jena, R. Mehta, et al, Antimicrobial peptides
and biogenic silver nanoparticles kill mycobacterium
without eliciting DNA damage and cytotoxicity in mouse
macrophages, Antimicrob. Agents Chemother. 57 (2013)
3688–3698.
[42] M. Yamanaka, K. Hara, J. Kudo, Bactericidal actions of a silver
ion solution on Escherichia coli studied by energy-filtering
transmission electron microscopy and proteomic analysis,
Appl. Environ. Microbiol. 71 (2005) 7589–7593.
[43] A. Kumar, P.K. Vemula, P.M. Ajayan, et al, Silver-nanoparticle
embedded antimicrobial paints based on vegetable oil, Nat.
Mater. 7 (2008) 236–241.
[44] K.R. Raghupathi, R.T. Koodali, A.C. Manna, Size-dependent
bacterial growth inhibition and mechanism of antibacterial
activity of zinc oxide nanoparticles, Langmuir 27 (2011) 4020–
4028.
[45] I. Azuma, Y. Yamamura, Studies on the firmly bound lipids of
human tubercle bacillus. II. Isolation of arabinose mycolate
and identification of its chemical structure, J. Biochem. 53
(1963) 275–278.
[46] K. Takayama, E.L. Armstrong, Metabolic role of free mycolic
acids inMycobacterium tuberculosis, J. Bacteriol. 130 (1977) 569–
570.
[47] J.O. Kilburn, J. Greenberg, Effect of ethambutol on the viable
cell count in Mycobacterium smegmatis, Antimicrob. Agents
Chemother. 11 (1977) 534–540.
[48] K. Takayama, E.L. Armstrong, K.A. Kunugi, et al, Inhibition by
ethambutol of mycolic acid transfer into the cell wall of
Mycobacterium smegmatis, Antimicrob. Agents Chemother. 16
(1979) 240–242.
